Specific Biologics
Toronto · Founded 2017
About Specific Biologics
Specific Biologics is developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. It designed to exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.
Company Facts
- Founded: 2017
- Legal name: Specific Biologics Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Funding stage: Seed
- Last round: Grant (Mar 2026)
- Website: specificbiologics.com
Social Profiles
Canonical: https://fsome.com/organization/specific-biologics-8459850 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.